Samsung Medical Center: Diabetes Mellitus, Type 2 trials
The registry lists 10 Diabetes Mellitus, Type 2 studies with Samsung Medical Center as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 1Phase 4 2No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Switching to E-Cigarettes After Type 2 Diabetes Diagnosis and Health OutcomesCompletedNCT07414355
- Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. SulfonylureasCompletedNCT07332156
- The Impact of Medication Adherence in Patients With Type 2 Diabetes and DisabilitiesCompletedNCT07052708
- Effectiveness of Individualized Automatic Coaching Message for Glycemic Management and Depressive SymptomCompletedNCT06769906Not applicable
- Digital Integrated Healthcare Platform in Patients With Type 2 DiabetesStatus unknownNCT04161170Not applicable
- Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal InsufficiencyCompletedNCT03667300Phase 2
- Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes MellitusCompletedNCT03552991Phase 4
- Effect of Monitoring of Step Number on DiabetesStatus unknownNCT03407222Not applicable
- Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and SitagliptinCompletedNCT01422590Phase 1
- The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 DiabetesCompletedNCT01404676Phase 4